|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Pricing and Reimbursement in India
Decision Resources, Inc., Sep 2009, Pages: 38
Faced with a dramatic slowdown in sales in mature pharmaceutical markets, multinational pharmaceutical companies are looking to substantially increase their sales in India and other emerging markets. The Indian market is growing by more than 10% per year, but foreign companies will need to overcome significant obstacles to succeed in a market currently dominated by domestic manufacturers.
Questions Answered in This Report
The Indian population is forecast to grow from its present size of 1.2 billion to 1.7 billion in 2050.
- How will the age breakdown of the population evolve over time?
- How will the balance between India’s urban and rural populations change in the coming years?
Only a minority of Indians have health insurance.
- What are the main forms of health insurance?
- How do most Indians fund healthcare and medications?
The Indian government controls the prices of 74 scheduled medicines.
- Which agents are subject to price control?
- How are prices of other drugs regulated?
- How does the government penalize overcharging for drugs?
- How do prices in India compare with prices in other markets?
- What pricing reforms is the Indian government contemplating?
Scope
- Demographic trends: population breakdown by age and sex; population breakdown by geographic distribution.
- Organization and funding of healthcare: overview of the Indian healthcare system; access to healthcare; health insurance; out-of-pocket expenditures.
- Pharmaceutical pricing: historical price controls; current price control system; price adjustments; penalties for overcharging for drugs; international price comparison; multinational companies’ pricing strategies.
- Outlook and implications for the pharmaceutical industry: encouraging commercial outlook; potential government reforms; opportunities and threats for multinationals.
Customers who bought this item also bought
Pricing, Reimbursement, and Market Access in the BRIC-MT Markets
Pharmaceutical Pricing, Reimbursement, and Market Access in Poland, Romania and Ukraine
Pharmaceutical Pricing, Reimbursement, and Market Access News in the Third Quarter of 2011
Market Access in the United States: An Uncertain Outlook
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
Pharmaceutical Pricing, Reimbursement, and Market Access in Turkey
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry
Indian Pharmaceutical Industry: Issues and Opportunities
|
|
|
|
